Nuclear factor erythroid-derived 2-like 2 (NFE2L2, Nrf2) mediates exercise-induced mitochondrial biogenesis and the anti-oxidant response in mice

被引:174
|
作者
Merry, Troy L. [1 ,2 ]
Ristow, Michael [1 ]
机构
[1] Swiss Fed Inst Technol, Energy Metab Lab, Schwerzenbach, Switzerland
[2] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2016年 / 594卷 / 18期
基金
瑞士国家科学基金会;
关键词
EXTENDS LIFE-SPAN; SKELETAL-MUSCLE CELLS; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; VITAMIN-C; INSULIN-RESISTANCE; ADAPTATIONS; ACTIVATION; EXPRESSION; PGC-1-ALPHA;
D O I
10.1113/JP271957
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Reactive oxygen species (ROS) and nitric oxide (NO) regulate exercise-induced nuclear factor erythroid 2-related factor 2 (NFE2L2) expression in skeletal muscle. NFE2L2 is required for acute exercise-induced increases in skeletal muscle mitochondrial biogenesis genes, such as nuclear respiratory factor 1 (NRF-1) and mitochondrial transcription factor A, and anti-oxidant genes, such as superoxide dismutase (SOD)1, SOD2 and catalase. Following exercise training mice with impaired NFE2L2 expression have reduced exercise performance, energy expenditure, mitochondrial volume and anti-oxidant activity. In muscle cells, ROS and NO can regulate mitochondrial biogenesis via a NFE2L2/NRF-1-dependent pathway. AbstractRegular exercise induces adaptations to skeletal muscle, which can include mitochondrial biogenesis and enhanced anti-oxidant reserves. These adaptations and others are at least partly responsible for the improved health of physically active individuals. Reactive oxygen species (ROS) and nitric oxide (NO) are produced during exercise and may mediate the adaptive response to exercise in skeletal muscle. However, the mechanisms through which they act are unclear. In the present study, we aimed to determine the role of the redox-sensitive transcription factor nuclear factor erythroid-derived 2-like 2 (NFE2L2) in acute exercise- and training-induced mitochondrial biogenesis and the anti-oxidant response. We report that ROS and NO regulate acute exercise-induced expression of NFE2L2 in mouse skeletal muscle and muscle cells, and that deficiency in NFE2L2 prevents normal acute treadmill exercise-induced increases in mRNA of the mitochondrial biogenesis markers, nuclear respiratory factor 1 (NRF-1) and mitochondrial transcription factor A (mtTFA), and the anti-oxidants superoxide dismutase (SOD) 1 and 2, as well as catalase, in mouse gastrocnemius muscle. Furthermore, after 5weeks of treadmill exercise training, mice deficient in NFE2L2 had reduced exercise capacity and whole body energy expenditure, as well as skeletal muscle mitochondrial mass and SOD activity, compared to wild-type littermates. In C2C12 myoblasts, acute treatment with exogenous H2O2 (ROS)- and diethylenetriamine/NO adduct (NO donor) induced increases in mtTFA, which was prevented by small interfering RNA and short hairpin RNA knockdown of either NFE2L2 or NRF-1. Our results suggest that, during exercise, ROS and NO can act via NFE2L2 to functionally regulate skeletal muscle mitochondrial biogenesis and anti-oxidant defence gene expression.
引用
收藏
页码:5195 / 5207
页数:13
相关论文
共 50 条
  • [1] Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and exercise
    Mallard, Alistair R.
    Spathis, Jemima G.
    Coombes, Jeff S.
    FREE RADICAL BIOLOGY AND MEDICINE, 2020, 160 : 471 - 479
  • [2] Chlorella Ethanol Extract Induced Phase II Enzyme Through NFE2L2 (Nuclear Factor [Erythroid-Derived] 2-Like 2, NRF2) Activation and Protected Ethanol-Induced Hepatoxicity
    Byun, Hee-Guk
    Lee, Jung Kwon
    JOURNAL OF MEDICINAL FOOD, 2015, 18 (02) : 182 - 189
  • [3] Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) is a novel therapeutic target for diabetic complications
    Xu, Xiaohong
    Luo, Ping
    Wang, Yangwei
    Cui, Yingchun
    Miao, Lining
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2013, 41 (01) : 13 - 19
  • [4] Silencing of Nuclear factor (erythroid-derived 2) -like 2 (NFE2L2) impairs growth and proliferation of hepatoblastoma cells
    Bansal, Hima
    Chen, Tina
    Lai, Zhao
    Parsons, Donald
    Trevino, Lisa
    Lopez-Terrada, Dolores
    Finegold, Milton
    Rakheja, Dinesh
    Comerford, Sarah
    Hammer, Robert
    Pollock, Bradley
    Hung, Jaclyn
    Bansal, Sanjay
    Chen, Yidong
    Tomlinson, Gail
    CANCER RESEARCH, 2014, 74 (20)
  • [5] Basic Concepts on the Role of Nuclear Factor Erythroid-Derived 2-Like 2 (Nrf2) in Age-Related Diseases
    Francisqueti-Ferron, Fabiane Valentini
    Togneri Ferron, Artur Junio
    Garcia, Jessica Leite
    Vagula de Almeida Silva, Carol Cristina
    Costa, Mariane Rovero
    Gregolin, Cristina Schmitt
    Moreto, Fernando
    Ferreira, Ana Lucia A.
    Minatel, Igor Otavio
    Correa, Camila Renata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (13)
  • [6] Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer
    Merikallio, Heta
    Paakko, Paavo
    Kinnula, Vuokko L.
    Harju, Terttu
    Soini, Ylermi
    HUMAN PATHOLOGY, 2012, 43 (04) : 577 - 584
  • [7] NADPH Oxidase 4 (Nox4) Suppresses Mitochondrial Biogenesis and Bioenergetics in Lung Fibroblasts via a Nuclear Factor Erythroid-derived 2-like 2 (Nrf2)-dependent Pathway
    Bernard, Karen
    Logsdon, Naomi J.
    Miguel, Veronica
    Benavides, Gloria A.
    Zhang, Jianhua
    Carter, A. Brent
    Darley-Usmar, Victor M.
    Thannickal, Victor J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (07) : 3029 - 3038
  • [8] The Complicated Role of Nuclear Factor Erythroid-Derived 2-Like 2 in Allergy and Asthma
    Rockwell, Cheryl E.
    Jin, Yining
    Boss, Allison P.
    Kaiser, Luca M.
    Awali, Saamera
    DRUG METABOLISM AND DISPOSITION, 2022, 50 (04) : 500 - 507
  • [9] Aryl hydrocarbon receptor (AHR) and nuclear factor erythroid-derived 2-like 2 (NRF2): An important crosstalk in the gut-liver axis
    Huchzermeier, Rosanna
    Vorst, Emiel P. C. van der
    BIOCHEMICAL PHARMACOLOGY, 2025, 233
  • [10] Characterization of the Nuclear Factor (Erythroid-Derived 2)-Like 2 (NRF2) Response in Autosomal Dominant Polycystic Kindney Disease (ADPKD)
    Lutsic, Jared
    Tug, Ali
    Adrian, Alexis
    Torres, Vicente
    Irazabal, Maria
    FASEB JOURNAL, 2020, 34